Table of Contents 1 Study Coverage 1.1 Dibigatran Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Dibigatran Market Size Growth Rate by Product 1.4.2 Pradaxa 1.4.3 Pradax 1.4.4 Prazaxa 1.5 Market by End User 1.5.1 Global Dibigatran Market Size Growth Rate by End User 1.5.2 stroke 1.5.3 deep vein thrombosis 1.5.4 pulmonary embolism 1.5.5 systemic embolism 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Dibigatran Market Size 2.1.1 Global Dibigatran Revenue 2014-2025 2.1.2 Global Dibigatran Sales 2014-2025 2.2 Dibigatran Growth Rate by Regions 2.2.1 Global Dibigatran Sales by Regions 2.2.2 Global Dibigatran Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Dibigatran Sales by Manufacturers 3.1.1 Dibigatran Sales by Manufacturers 3.1.2 Dibigatran Sales Market Share by Manufacturers 3.1.3 Global Dibigatran Market Concentration Ratio (CR5 and HHI) 3.2 Dibigatran Revenue by Manufacturers 3.2.1 Dibigatran Revenue by Manufacturers (2014-2019) 3.2.2 Dibigatran Revenue Share by Manufacturers (2014-2019) 3.3 Dibigatran Price by Manufacturers 3.4 Dibigatran Manufacturing Base Distribution, Product Types 3.4.1 Dibigatran Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Dibigatran Product Type 3.4.3 Date of International Manufacturers Enter into Dibigatran Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Dibigatran Sales by Product 4.2 Global Dibigatran Revenue by Product 4.3 Dibigatran Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Dibigatran Breakdown Data by End User 6 North America 6.1 North America Dibigatran by Countries 6.1.1 North America Dibigatran Sales by Countries 6.1.2 North America Dibigatran Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Dibigatran by Product 6.3 North America Dibigatran by End User 7 Europe 7.1 Europe Dibigatran by Countries 7.1.1 Europe Dibigatran Sales by Countries 7.1.2 Europe Dibigatran Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Dibigatran by Product 7.3 Europe Dibigatran by End User 8 Asia Pacific 8.1 Asia Pacific Dibigatran by Countries 8.1.1 Asia Pacific Dibigatran Sales by Countries 8.1.2 Asia Pacific Dibigatran Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Dibigatran by Product 8.3 Asia Pacific Dibigatran by End User 9 Central & South America 9.1 Central & South America Dibigatran by Countries 9.1.1 Central & South America Dibigatran Sales by Countries 9.1.2 Central & South America Dibigatran Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Dibigatran by Product 9.3 Central & South America Dibigatran by End User 10 Middle East and Africa 10.1 Middle East and Africa Dibigatran by Countries 10.1.1 Middle East and Africa Dibigatran Sales by Countries 10.1.2 Middle East and Africa Dibigatran Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Dibigatran by Product 10.3 Middle East and Africa Dibigatran by End User 11 Company Profiles 11.1 Pfizer, Inc. (US) 11.1.1 Pfizer, Inc. (US) Company Details 11.1.2 Company Business Overview 11.1.3 Pfizer, Inc. (US) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Pfizer, Inc. (US) Dibigatran Products Offered 11.1.5 Pfizer, Inc. (US) Recent Development 11.2 Bayer Healthcare AG (Germany) 11.2.1 Bayer Healthcare AG (Germany) Company Details 11.2.2 Company Business Overview 11.2.3 Bayer Healthcare AG (Germany) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Bayer Healthcare AG (Germany) Dibigatran Products Offered 11.2.5 Bayer Healthcare AG (Germany) Recent Development 11.3 GlaxoSmithKline Plc. (UK) 11.3.1 GlaxoSmithKline Plc. (UK) Company Details 11.3.2 Company Business Overview 11.3.3 GlaxoSmithKline Plc. (UK) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.3.4 GlaxoSmithKline Plc. (UK) Dibigatran Products Offered 11.3.5 GlaxoSmithKline Plc. (UK) Recent Development 11.4 Boehringer Ingelheim (Germany) 11.4.1 Boehringer Ingelheim (Germany) Company Details 11.4.2 Company Business Overview 11.4.3 Boehringer Ingelheim (Germany) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Boehringer Ingelheim (Germany) Dibigatran Products Offered 11.4.5 Boehringer Ingelheim (Germany) Recent Development 11.5 Sanofi S.A. (France) 11.5.1 Sanofi S.A. (France) Company Details 11.5.2 Company Business Overview 11.5.3 Sanofi S.A. (France) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Sanofi S.A. (France) Dibigatran Products Offered 11.5.5 Sanofi S.A. (France) Recent Development 11.6 Abbott India Limited (India) 11.6.1 Abbott India Limited (India) Company Details 11.6.2 Company Business Overview 11.6.3 Abbott India Limited (India) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Abbott India Limited (India) Dibigatran Products Offered 11.6.5 Abbott India Limited (India) Recent Development 11.7 Aspen Holdings (South Africa) 11.7.1 Aspen Holdings (South Africa) Company Details 11.7.2 Company Business Overview 11.7.3 Aspen Holdings (South Africa) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Aspen Holdings (South Africa) Dibigatran Products Offered 11.7.5 Aspen Holdings (South Africa) Recent Development 11.8 Bristol-Myers Squibb Company (US) 11.8.1 Bristol-Myers Squibb Company (US) Company Details 11.8.2 Company Business Overview 11.8.3 Bristol-Myers Squibb Company (US) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Bristol-Myers Squibb Company (US) Dibigatran Products Offered 11.8.5 Bristol-Myers Squibb Company (US) Recent Development 11.9 Eisai Inc. (US) 11.9.1 Eisai Inc. (US) Company Details 11.9.2 Company Business Overview 11.9.3 Eisai Inc. (US) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Eisai Inc. (US) Dibigatran Products Offered 11.9.5 Eisai Inc. (US) Recent Development 11.10 Mitsubishi Tanabe Pharma Corporation (Japan) 11.10.1 Mitsubishi Tanabe Pharma Corporation (Japan) Company Details 11.10.2 Company Business Overview 11.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Products Offered 11.10.5 Mitsubishi Tanabe Pharma Corporation (Japan) Recent Development 11.11 Teva Pharmaceutical Industries Ltd. (Israel) 12 Future Forecast 12.1 Dibigatran Market Forecast by Regions 12.1.1 Global Dibigatran Sales Forecast by Regions 2019-2025 12.1.2 Global Dibigatran Revenue Forecast by Regions 2019-2025 12.2 Dibigatran Market Forecast by Product 12.2.1 Global Dibigatran Sales Forecast by Product 2019-2025 12.2.2 Global Dibigatran Revenue Forecast by Product 2019-2025 12.3 Dibigatran Market Forecast by End User 12.4 North America Dibigatran Forecast 12.5 Europe Dibigatran Forecast 12.6 Asia Pacific Dibigatran Forecast 12.7 Central & South America Dibigatran Forecast 12.8 Middle East and Africa Dibigatran Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Dibigatran Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Dibigatran Product Picture Table Dibigatran Market Segments Table Key Manufacturers Dibigatran Covered Table Global Dibigatran Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$) Figure Global Dibigatran Sales Market Share by Product 2014-2025 Figure Pradaxa Product Picture Table Major Manufacturers of Pradaxa Figure Pradax Product Picture Table Major Manufacturers of Pradax Figure Prazaxa Product Picture Table Major Manufacturers of Prazaxa Table Global Dibigatran Market Size Growth Rate by End User 2019-2025 (Units) Figure stroke Figure deep vein thrombosis Figure pulmonary embolism Figure systemic embolism Figure Dibigatran Report Years Considered Figure Global Dibigatran Market Size 2014-2025 (Million US$) Figure Global Dibigatran Sales 2014-2025 (Units) Table Global Dibigatran Market Size by Regions 2014-2019 (Units) & (Million US$) Table Global Dibigatran Sales by Regions 2014-2019 (Units) Table Global Dibigatran Sales Market Share by Regions 2014-2019 Figure Global Dibigatran Sales Market Share by Regions 2014-2019 Figure 2018 Global Dibigatran Sales Market Share by Regions Table Global Dibigatran Revenue by Regions 2014-2019 (Million US$) Table Global Dibigatran Revenue Market Share by Regions 2014-2019 Figure Global Dibigatran Revenue Market Share by Regions 2014-2019 Figure 2018 Global Dibigatran Revenue Market Share by Regions Table Global Dibigatran Sales by Manufacturers (2014-2019) (Units) Table Global Dibigatran Sales Share by Manufacturers (2014-2019) Figure Global Dibigatran Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Dibigatran Revenue by Manufacturers (2014-2019) (Million USD) Table Dibigatran Revenue Share by Manufacturers (2014-2019) Figure Dibigatran Value Share by Manufacturers in 2018 Table Key Manufacturers Dibigatran Price (2014-2019) (K USD/Unit) Table Dibigatran Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Dibigatran Product Type Table Date of International Manufacturers Enter into Dibigatran Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Dibigatran Sales by Product (2014-2019) (Units) Table Global Dibigatran Sales Share by Product (2014-2019) Figure Global Dibigatran Sales Market Share by Product (2014-2019) Figure Global Dibigatran Sales Market Share by Product in 2018 Table Global Dibigatran Revenue by Product (2014-2019) (Million US$) Table Global Dibigatran Revenue Share by Product (2014-2019) Figure Global Dibigatran Revenue Market Share by Product (2014-2019) Figure Global Dibigatran Revenue Market Share by Product in 2018 Table Dibigatran Price by Product 2014-2019 (K USD/Unit) Table Global Dibigatran Sales by End User (2014-2019) (Units) Table Global Dibigatran Sales Share by End User (2014-2019) Figure Global Sales Dibigatran Market Share by End User (2014-2019) Figure Global Sales Dibigatran Market Share by End User in 2018 Figure North America Dibigatran Sales Growth Rate 2014-2019 (Units) Figure North America Dibigatran Revenue Growth Rate 2014-2019 (Million US$) Table North America Dibigatran Sales by Countries (2014-2019) (Units) Table North America Dibigatran Sales Market Share by Countries (2014-2019) Figure 2018 North America Dibigatran Sales Market Share by Countries Table North America Dibigatran Revenue by Countries (2014-2019) (Million US$) Table North America Dibigatran Revenue Market Share by Countries (2014-2019) Figure 2018 North America Dibigatran Revenue Market Share by Countries Figure United States Dibigatran Sales Growth Rate (2014-2019) (Units) Figure United States Dibigatran Revenue Growth Rate (2014-2019) (Units) Figure Canada Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Canada Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Mexico Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Table North America Dibigatran Sales by Product (2014-2019) (Units) Table North America Dibigatran Sales Market Share by Product (2014-2019) Figure 2018 North America Dibigatran Market Share by Product Table North America Dibigatran Sales by End User (2014-2019) (Units) Table North America Dibigatran Sales Market Share by End User (2014-2019) Figure 2018 North America Dibigatran Market Share by End User Figure Europe Dibigatran Sales Growth Rate 2014-2019 (Units) Figure Europe Dibigatran Revenue Growth Rate 2014-2019 (Million US$) Table Europe Dibigatran Sales by Countries (2014-2019) (Units) Table Europe Dibigatran Sales Market Share by Countries (2014-2019) Figure 2018 Europe Dibigatran Sales Market Share by Countries Table Europe Dibigatran Revenue by Countries (2014-2019) (Million US$) Table Europe Dibigatran Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Dibigatran Revenue Market Share by Countries Figure Germany Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Germany Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure France Dibigatran Sales Growth Rate (2014-2019) (Units) Figure France Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure UK Dibigatran Sales Growth Rate (2014-2019) (Units) Figure UK Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Italy Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Russia Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Table Europe Dibigatran Sales by Product (2014-2019) (Units) Table Europe Dibigatran Sales Market Share by Product (2014-2019) Figure 2018 Europe Dibigatran Market Share by Product Table Europe Dibigatran Sales by End User (2014-2019) (Units) Table Europe Dibigatran Sales Market Share by End User (2014-2019) Figure 2018 Europe Dibigatran Market Share by End User Figure Asia Pacific Dibigatran Sales Growth Rate 2014-2019 (Units) Figure Asia Pacific Dibigatran Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Dibigatran Sales by Countries (2014-2019) (Units) Table Asia Pacific Dibigatran Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Dibigatran Sales Market Share by Countries Table Asia Pacific Dibigatran Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Dibigatran Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Dibigatran Revenue Market Share by Countries Figure China Dibigatran Sales Growth Rate (2014-2019) (Units) Figure China Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Japan Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Korea Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure India Dibigatran Sales Growth Rate (2014-2019) (Units) Figure India Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Australia Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Indonesia Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Malaysia Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Philippines Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Thailand Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Vietnam Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Singapore Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Dibigatran Sales by Product (2014-2019) (Units) Table Asia Pacific Dibigatran Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Dibigatran Market Share by Product Table Asia Pacific Dibigatran Sales by End User (2014-2019) (Units) Table Asia Pacific Dibigatran Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Dibigatran Market Share by End User Figure Central & South America Dibigatran Sales Growth Rate 2014-2019 (Units) Figure Central & South America Dibigatran Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Dibigatran Sales by Countries (2014-2019) (Units) Table Central & South America Dibigatran Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Dibigatran Sales Market Share by Countries Table Central & South America Dibigatran Revenue by Countries (2014-2019) (Million US$) Table Central & South America Dibigatran Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Dibigatran Revenue Market Share by Countries Figure Brazil Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Brazil Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Argentina Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Dibigatran Sales by Product (2014-2019) (Units) Table Central & South America Dibigatran Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Dibigatran Market Share by Product Table Central & South America Dibigatran Sales by End User (2014-2019) (Units) Table Central & South America Dibigatran Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Dibigatran Market Share by End User Figure Middle East and Africa Dibigatran Sales Growth Rate 2014-2019 (Units) Figure Middle East and Africa Dibigatran Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Dibigatran Sales by Countries (2014-2019) (Units) Table Middle East and Africa Dibigatran Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Dibigatran Sales Market Share by Countries Table Middle East and Africa Dibigatran Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Dibigatran Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Dibigatran Revenue Market Share by Countries Figure GCC Countries Dibigatran Sales Growth Rate (2014-2019) (Units) Figure GCC Countries Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Turkey Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Dibigatran Sales Growth Rate (2014-2019) (Units) Figure Egypt Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Dibigatran Sales Growth Rate (2014-2019) (Units) Figure South Africa Dibigatran Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Dibigatran Sales by Product (2014-2019) (Units) Table Middle East and Africa Dibigatran Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Dibigatran Market Share by Product Table Middle East and Africa Dibigatran Sales by End User (2014-2019) (Units) Table Middle East and Africa Dibigatran Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Dibigatran Market Share by End User Table Pfizer, Inc. (US) Company Details Table Pfizer, Inc. (US) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Pfizer, Inc. (US) Recent Development Table Bayer Healthcare AG (Germany) Company Details Table Bayer Healthcare AG (Germany) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Bayer Healthcare AG (Germany) Recent Development Table GlaxoSmithKline Plc. (UK) Company Details Table GlaxoSmithKline Plc. (UK) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline Plc. (UK) Recent Development Table Boehringer Ingelheim (Germany) Company Details Table Boehringer Ingelheim (Germany) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim (Germany) Recent Development Table Sanofi S.A. (France) Company Details Table Sanofi S.A. (France) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Sanofi S.A. (France) Recent Development Table Abbott India Limited (India) Company Details Table Abbott India Limited (India) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Abbott India Limited (India) Recent Development Table Aspen Holdings (South Africa) Company Details Table Aspen Holdings (South Africa) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Aspen Holdings (South Africa) Recent Development Table Bristol-Myers Squibb Company (US) Company Details Table Bristol-Myers Squibb Company (US) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Bristol-Myers Squibb Company (US) Recent Development Table Eisai Inc. (US) Company Details Table Eisai Inc. (US) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Eisai Inc. (US) Recent Development Table Mitsubishi Tanabe Pharma Corporation (Japan) Company Details Table Mitsubishi Tanabe Pharma Corporation (Japan) Dibigatran Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2014-2019) Table Mitsubishi Tanabe Pharma Corporation (Japan) Recent Development Table Teva Pharmaceutical Industries Ltd. (Israel) Company Details Table Global Dibigatran Sales Forecast by Regions 2019-2025 (Units) Table Global Dibigatran Sales Market Share Forecast by Regions 2019-2025 Table Global Dibigatran Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Dibigatran Revenue Market Share Forecast by Regions 2019-2025 Table Global Dibigatran Sales Forecast by Product 2019-2025 (Units) Table Global Dibigatran Sales Market Share Forecast by Product 2019-2025 Table Global Dibigatran Revenue Forecast by Product 2019-2025 (Million US$) Table Global Dibigatran Revenue Market Share Forecast by Product 2019-2025 Table Global Dibigatran Sales Forecast by End User 2019-2025 (Units) Table Global Dibigatran Sales Market Share Forecast by End User 2019-2025 Figure North America Dibigatran Sales Growth Rate Forecast (2019-2025) (Units) Figure North America Dibigatran Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Dibigatran Sales Growth Rate Forecast (2019-2025) (Units) Figure Europe Dibigatran Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Dibigatran Sales Growth Rate Forecast (2019-2025) (Units) Figure Asia Pacific Dibigatran Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Dibigatran Sales Growth Rate Forecast (2019-2025) (Units) Figure Central & South America Dibigatran Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Dibigatran Sales Growth Rate Forecast (2019-2025) (Units) Figure Middle East and Africa Dibigatran Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Dibigatran Value Chain Table Dibigatran Customers List Table Dibigatran Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel)